We report favorable results of the long term use of mycophenolate in the treatment of three patients with myasthenia gravis (MG), two patients with chronic inflammatory demyelinating polyneuropathy (CIDP), one patient with secondary polymyositis (PM), and one patient with inclusion body myositis (...
Pediatrics- De Novo Kidney transplantation PK Study with Long Term Follow-Up One open-label, safety and pharmacokinetic study of CELLCEPT oral suspension 600 mg/m2 twice daily (up to 1 g twice daily) in combination with cyclosporine and corticosteroids was performed at centers in the United Sta...
CellCept is not recommended for use during pregnancy because of possible harm to the fetus. Women of childbearing age should have a negative pregnancy test within 1 week of starting this medication. Use two forms of birth control starting 4 weeks before beginning therapy, and continue for at lea...
Clinical trials using FK 506 (Tacrolimus)-based immunosuppression after intestinal transplantation are underway. Long-term survivals have been limited by t... M.,Spada,and,... - 《Transplantation Proceedings》 被引量: 13发表: 1997年 加载更多0...
BACKGROUND: Long-term maintenance immunosuppression with cyclosporine (CsA) is associated with chronic transplant nephropathy and adverse effects on blood ... D Abramowicz,D Manas,M Lao,... - 《Transplantation》 被引量: 87发表: 2002年 Generic immunosuppression in solid organ transplantation: systemati...
CELLCEPT Intravenous must be reconstituted before use [seePreparation Instructions Of Oral Suspension And Intravenous For Pharmacists]. CELLCEPT Intravenous is incompatible with other intravenous infusion solutions and should not be mixed or administered concurrently via the same infusion catheter with other...
Future studies have to show whether the use of MMF in combination with other immunosuppressants may allow to reduce the doses of the most toxic ones. In addition, long-term studies are needed to prove its potential protective effect on the occurrence of chronic rejection as suggested by ...
Future studies have to show whether the use of MMF in combination with other immunosuppressants may allow to reduce the doses of the most toxic ones. In addition, long-term studies are needed to prove its potential protective effect on the occurrence of chronic rejection as suggested by ...
Long-term Results of Immunosuppressive Therapy with Mycophenolate Mofetil (CellCept®) for Keratoplasty in High-risk Patients Conventional long-term immunosuppressive treatmentin high-risk patients undergoing keratoplasty may cause severesystemic side effects. In solid organ transplantation Mycophenolatemofetil...
FULL DOSE MYCOPHENOLATE MOFETIL (CELLCEPT) WITH LOW DOSE TACROLIMUS OPTIMIZES RENAL FUNCTION IN LONG TERM RENAL TRANSPLANT PATIENTS; RESULTS OF THE TRANCEPT STAY STUDY: 1711hairy surfacessuperhydrophobicityfree energy analysisload-carrying capacity